Oncology Institute Inc
TOI3.545USD
-0.265-6.96%
收盘 11/07, 16:00（美东）报价延迟15分钟
330.68M总市值
亏损市盈率 TTM
关于 Oncology Institute Inc 公司
肿瘤研究所是一家以价值为基础的肿瘤学公司。该公司管理社区肿瘤学诊所，为美国 15 个市场和 5 个州的 83 个诊所的患者提供服务。该公司的部门包括患者服务、药房和临床试验及其他。其管理的诊所提供一系列医学肿瘤学服务，包括医生服务、内部输液和药房、放射、门诊血液制品输血等计划以及全天候患者支持。该公司通过 TOI Clinical Research, LLC (TCR) 为癌症患者提供和管理临床试验服务和研究。它还为独立肿瘤诊所拥有的 14 个诊所提供管理服务。该公司及其附属提供商与服务于各种患者的付款人建立了合同关系，包括医疗保险优势计划 (MA)、医疗补助计划和商业患者。
Oncology Institute Inc简介
公司代码TOI
公司名称Oncology Institute Inc
上市日期Mar 13, 2020
CEODr. Daniel Virnich, M.D.
员工数量825
证券类型Ordinary Share
年结日Mar 13
公司地址18000 Studebaker Rd
城市CERRITOS
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编90703
电话15627353226
网址https://theoncologyinstitute.com/
公司代码TOI
上市日期Mar 13, 2020
CEODr. Daniel Virnich, M.D.
Oncology Institute Inc公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Daniel Virnich, M.D.
Dr. Daniel Virnich, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
1.18M
-1.69%
Mr. Brad Hively
Mr. Brad Hively
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
712.03K
+51.10%
Mr. Robert Ross Carter
Mr. Robert Ross Carter
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
235.17K
-0.68%
Dr. Mohit Kaushal
Dr. Mohit Kaushal
Independent Director
Independent Director
198.04K
--
Dr. Yale Podnos
Dr. Yale Podnos
Chief Medical Officer
Chief Medical Officer
193.04K
-0.92%
Ms. Anne Mcgeorge
Ms. Anne Mcgeorge
Independent Chairman of the Board
Independent Chairman of the Board
183.35K
--
Mr. Gabriel Ling
Mr. Gabriel Ling
Independent Director
Independent Director
109.06K
--
Ms. Kristin England
Ms. Kristin England
Chief Administrative Officer
Chief Administrative Officer
98.04K
--
Mr. Mark L. Pacala
Mr. Mark L. Pacala
Independent Director
Independent Director
--
--
Ms. Karen M. Johnson
Ms. Karen M. Johnson
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Daniel Virnich, M.D.
Dr. Daniel Virnich, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
1.18M
-1.69%
Mr. Brad Hively
Mr. Brad Hively
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
712.03K
+51.10%
Mr. Robert Ross Carter
Mr. Robert Ross Carter
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
235.17K
-0.68%
Dr. Mohit Kaushal
Dr. Mohit Kaushal
Independent Director
Independent Director
198.04K
--
Dr. Yale Podnos
Dr. Yale Podnos
Chief Medical Officer
Chief Medical Officer
193.04K
-0.92%
Ms. Anne Mcgeorge
Ms. Anne Mcgeorge
Independent Chairman of the Board
Independent Chairman of the Board
183.35K
--
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
业务USD
名称
营收
占比
Dispensary revenue
62.57M
52.23%
FFS revenue
37.05M
30.92%
Capitated revenue
18.84M
15.73%
Clinical research trials and other revenue
1.34M
1.12%
暂无数据
业务
地区
业务USD
名称
营收
占比
Dispensary revenue
62.57M
52.23%
FFS revenue
37.05M
30.92%
Capitated revenue
18.84M
15.73%
Clinical research trials and other revenue
1.34M
1.12%
股东统计
更新时间: 10月4日 周六
更新时间: 10月4日 周六
持股股东
股东类型
持股股东
持股股东
占比
M33 Growth LLC
9.12%
The Vanguard Group, Inc.
4.86%
OncologyCare Partners LLC
4.40%
Deerfield Management Company, L.P.
3.59%
BlackRock Institutional Trust Company, N.A.
3.20%
其他
74.83%
持股股东
持股股东
占比
M33 Growth LLC
9.12%
The Vanguard Group, Inc.
4.86%
OncologyCare Partners LLC
4.40%
Deerfield Management Company, L.P.
3.59%
BlackRock Institutional Trust Company, N.A.
3.20%
其他
74.83%
股东类型
持股股东
占比
Investment Advisor
16.49%
Hedge Fund
9.69%
Venture Capital
9.17%
Investment Advisor/Hedge Fund
6.83%
Individual Investor
4.49%
Corporation
4.40%
Research Firm
0.43%
Private Equity
0.27%
Bank and Trust
0.16%
其他
48.09%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
144
40.27M
43.06%
-3.18M
2025Q2
119
39.72M
44.51%
-19.63M
2025Q1
137
46.36M
52.04%
-13.47M
2024Q4
138
45.05M
59.62%
-19.81M
2024Q3
139
50.89M
67.39%
-11.59M
2024Q2
143
57.80M
76.77%
-3.05M
2024Q1
146
56.10M
75.87%
-3.90M
2023Q4
143
57.48M
77.79%
-4.30M
2023Q3
176
58.70M
79.97%
-14.73M
2023Q2
180
58.28M
81.90%
-25.39M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
M33 Growth LLC
8.52M
9.12%
-5.15M
-37.65%
Sep 04, 2025
The Vanguard Group, Inc.
4.28M
4.58%
+2.53M
+144.52%
Jun 30, 2025
OncologyCare Partners LLC
4.11M
4.4%
--
--
Mar 26, 2025
Deerfield Management Company, L.P.
3.36M
3.59%
--
--
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
3.00M
3.2%
+2.74M
+1088.12%
Jun 30, 2025
CenterBook Partners LP
715.90K
0.77%
+715.90K
--
Jun 30, 2025
Balyasny Asset Management LP
2.52M
2.69%
+371.00K
+17.28%
Jun 30, 2025
Josh Arnold Investment Consultant, LLC
2.45M
2.62%
+457.65K
+23.01%
Jun 30, 2025
Marshall Wace LLP
1.48M
1.58%
+1.48M
--
Jun 30, 2025
Geode Capital Management, L.L.C.
1.28M
1.37%
+893.70K
+231.68%
Jun 30, 2025
查看更多
持股ETF
更新时间: 11月6日 周四
更新时间: 11月6日 周四
机构名称
占比
Vanguard US Momentum Factor ETF
0.1%
iShares Micro-Cap ETF
0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
Global X Russell 2000 ETF
0.01%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares UltraPro Russell2000
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
Vanguard US Momentum Factor ETF
占比0.1%
iShares Micro-Cap ETF
占比0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0.03%
Global X Russell 2000 ETF
占比0.01%
ProShares Hedge Replication ETF
占比0.01%
iShares Russell 2000 ETF
占比0.01%
Proshares Ultra Russell 2000
占比0.01%
ProShares UltraPro Russell2000
占比0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
占比0.01%
iShares Russell 2000 Growth ETF
占比0.01%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
